Can This AI Stock Bounce Back in 2026?
2026-03-08 12:15:00 ET
Artificial intelligence (AI) is all the rage on Wall Street these days, but not every AI stock is equally successful. Some of the bigger names in the field, like Nvidia , have seen their shares soar in recent years, while other, smaller ones, like Recursion Pharmaceuticals (NASDAQ: RXRX) , continue to struggle.
Recursion, a healthcare-focused AI company, could have some catalysts in the next 12 to 18 months, however. Can the stock bounce back this year?
Image source: Getty Images.
NASDAQ: RXRX
RXRX Trading
4.52% G/L:
$3.405 Last:
9,334,431 Volume:
$3.35 Open:



